SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006288
Filing Date
2022-04-28
Accepted
2022-04-28 16:15:10
Documents
7
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220608xdef14a.htm DEF 14A 1891888
2 GRAPHIC tmb-20220608xdef14a003.jpg GRAPHIC 1695
3 GRAPHIC tmb-20220608xdef14a018.jpg GRAPHIC 5660
4 GRAPHIC tmb-20220608xdef14a007.jpg GRAPHIC 53257
5 GRAPHIC tmb-20220608xdef14a004.jpg GRAPHIC 58633
6 GRAPHIC tmb-20220608xdef14a001.jpg GRAPHIC 14201
7 GRAPHIC tmb-20220608xdef14a002.jpg GRAPHIC 3678
  Complete submission text file 0001558370-22-006288.txt   2082822
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 22866740
SIC: 2834 Pharmaceutical Preparations